Martha Morrell, Chief Medical Officer at NeuroPace Inc (NPCE), sold 2,730 shares at $10.14 ($28K) on 2023-12-20, disclosed to the SEC on 2023-12-22.
Scheduled sale ($28k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| NPCE | SELL | 2025-01-31 | $5K | — | Filing → |
| NPCE | SELL | 2025-01-28 | $48K | — | Filing → |
| NPCE | SELL | 2024-02-06 | $531K | — | Filing → |